BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  uniQure Researchers Swap Out Lead Drug for a Better Prospect

  The company plans to expeditiously advance AMT-061 instead of AMT-060.

  October 19, 2017

   · 

  10 min read
• Pharm Country

  Q BioMed Announces Identification and Production of New Proprietary Drug Candidate for Pediatric Nonverbal Disorder

  Q BioMed today that it has successfully developed a new and proprietary analog of QBM-001 in partnership with Sphaera Pharma for its intended use in pediatric developmental nonverbal disorder.

  October 19, 2017

   · 

  3 min read
• Biotech Beach

  Spinal Singularity Closes Seed Funding Round for $3.1M

  Derek Herrera, the founder of Spinal Singularity, announced the closing of an equity investment in the amount of $3.1M.

  October 19, 2017

   · 

  2 min read
• Business

  RPRD Diagnostics Partners with St. Jude Children’s Research Hospital to Offer Comprehensive Pharmacogenetics Testing

  RPRDDiagnostics, a privately-held, Wisconsin-based precision medicine company, today announced a collaboration with St. Jude Children’s Research Hospital.

  October 19, 2017

   · 

  5 min read
• Business

  CRH Medical to Announce Unaudited Third Quarter Results on November 1, 2017

  CRH Medical plans to release its unaudited results for the quarter ended September 30, 2017, on Wednesday, November 1, 2017 after market close.

  October 19, 2017

   · 

  1 min read
• Business

  Cerus to Release Third Quarter 2017 Results on November 2, 2017

  Cerus announced today that its third quarter results will be released on Thursday, November 2, 2017, after the close of the stock market.

  October 19, 2017

   · 

  1 min read
• Deals

  Pivot Pharma Executes Binding Letter of Intent to Acquire ACI Foods Inc.

  Pivot Pharmaceuticals, an emerging biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals, today announces the execution of a Binding Letter of Intent to acquire Absorbent Concepts Inc. (“ACI Foods” or “ACI”).

  October 19, 2017

   · 

  5 min read
• Business

  Alcami Establishes International Sales Office in Japan

  Alcami today announces the launch of its international sales office in Tokyo, Japan.

  October 19, 2017

   · 

  2 min read
• Business

  GIMDx and IncellDx Announce OEM and International Distribution Agreement for Single Cell Immuno-Oncology and Oncology Diagnostic Products in China

  GIMDx announced today that it has concluded an exclusive OEM and International Distribution agreement for IncellDx single cell immune-oncology and oncology diagnostic products in China.

  October 19, 2017

   · 

  3 min read
• Pharm Country

  CytoSorbents Release: CytoSorb Usage During Valve Replacement Surgery for Infective Endocarditis Helps Stabilize Patients and May Improve Survival

  CytoSorbents highlights the largest endocarditis valve replacement study using CytoSorb published to date entitled, “Hemoadsorption treatment of patients with acute infective endocarditis during surgery with cardiopulmonary bypass - a case series”.

  October 19, 2017

   · 

  8 min read